In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $1.74 in the prior trading day, Fractyl Health Inc (NASDAQ: GUTS) closed at $1.64, down -5.75%. In other words, the price has decreased by -$5.75 from its previous closing price. On the day, 4.19 million shares were traded. GUTS stock price reached its highest trading level at $1.8145 during the session, while it also had its lowest trading level at $1.64.
Ratios:
Our goal is to gain a better understanding of GUTS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.50. In the meantime, Its Debt-to-Equity ratio is 9.63 whereas as Long-Term Debt/Eq ratio is at 8.84.
On February 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.
On February 27, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $26.BofA Securities initiated its Buy rating on February 27, 2024, with a $26 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 80321624 and an Enterprise Value of 99638680. For the stock, the TTM Price-to-Sale (P/S) ratio is 1338.67 while its Price-to-Book (P/B) ratio in mrq is 12.59. Its current Enterprise Value per Revenue stands at 1660.645 whereas that against EBITDA is -1.04.
Stock Price History:
The Beta on a monthly basis for GUTS is 1.77, which has changed by -0.632287 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $4.92, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -5.50%, while the 200-Day Moving Average is calculated to be -14.46%.
Shares Statistics:
The stock has traded on average 412.39K shares per day over the past 3-months and 1310890 shares per day over the last 10 days, according to various share statistics. A total of 48.92M shares are outstanding, with a floating share count of 20.88M. Insiders hold about 57.37% of the company’s shares, while institutions hold 33.03% stake in the company. Shares short for GUTS as of 1749772800 were 2486895 with a Short Ratio of 6.03, compared to 1747267200 on 2855197. Therefore, it implies a Short% of Shares Outstanding of 2486895 and a Short% of Float of 10.2.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
